Commonwealth legislation

Health Insurance (Indium-labelled Octreotide Study) Determination 2010

RepealedCTH

This Act has been repealed and is no longer in force. It is retained for historical reference.

Jurisdiction

Commonwealth

Collection

legislative instrument

Plain English Summary

1/10 complexity

Incomplete document provided.

The text contains only the preliminary sections (cover page, name, commencement date, and revocation clause) of the Health Insurance (Indium-labelled Octreotide Study) Determination 2010.

Based on the title and the fact it is made under subsection 3C(1) of the Health Insurance Act 1973, this instrument likely relates to Medicare benefits for a clinical study involving Indium-labelled Octreotide (a radioactive tracer used in medical imaging for neuroendocrine tumours). However, the substantive provisions—such as eligibility criteria for patients, payment rules, or study parameters—are missing from the provided text.

JSON API Health / NDIS / medicines

Deep dive

Want the full deep dive?

Zoe can write the in-depth analysis on top of the summary above: how it works, who it affects and what each part actually does.

Current sections

Direct links to the current provisions in Health Insurance (Indium-labelled Octreotide Study) Determination 2010.

Health Insurance (Indium-labelled Octreotide Study) Determination 2010

meta-content-style-type: text/css meta-content-type: application/xhtml+xml; charset=utf-8 meta-generator: Aspose.Words for .NET 20.2

?xml version="1.0" encoding="utf-8" standalone="no"?>

View image in the official source

Health Insurance (Indium-labelled Octreotide Study) Determination 2010

I, RICHARD BARTLETT delegate of the Minister for Health and Ageing, make this Determination under subsection 3C(1) of the Health Insurance Act 1973.

Dated 15 June 2010

RICHARD BARTLETT

DELEGATE FOR THE MINISTER FOR HEALTH AND AGEING

Name of Rules

This Determination is the Health Insurance (Indium-labelled Octreotide Study) Determination 2010.

Commencement

This Determination commences on 1 July 2010.

Revocation

This Determination revokes the Health Insurance (Indium-labelled Octreotide Study) Determination HS/09/2006.

Note

1. All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See www.frli.gov.au

Source text

Sourced from the Federal Register of Legislation (legislation.gov.au), CC BY 4.0.

meta-content-style-type: text/css meta-content-type: application/xhtml+xml; charset=utf-8 meta-generator: Aspose.Words for .NET 20.2

?xml version="1.0" encoding="utf-8" standalone="no"?>

Health Insurance (Indium-labelled Octreotide Study) Determination 2010

I, RICHARD BARTLETT delegate of the Minister for Health and Ageing, make this Determination under subsection 3C(1) of the Health Insurance Act 1973.

Dated 15 June 2010

RICHARD BARTLETT

DELEGATE FOR THE MINISTER FOR HEALTH AND AGEING

Name of Rules

This Determination is the Health Insurance (Indium-labelled Octreotide Study) Determination 2010.

Commencement

This Determination commences on 1 July 2010.

Revocation

This Determination revokes the Health Insurance (Indium-labelled Octreotide Study) Determination HS/09/2006.

Note

1. All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See www.frli.gov.au

Read the source document